Zoetis (ZTS) Goodwill & Intangibles (2012 - 2026)
Zoetis' (ZTS) quarterly Goodwill & Intangibles came in at $3.7 billion in Q1 2026, down 1.61% year-on-year from $3.8 billion in Q1 2025, and down 0.93% on a QoQ basis from $3.8 billion in Q4 2025.
Zoetis (ZTS) Goodwill & Intangibles (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has 15 years of Goodwill & Intangibles data on file, last reported at $3.7 billion in Q1 2026.
- On a quarterly basis, Goodwill & Intangibles fell 1.61% year-over-year to $3.7 billion in Q1 2026; TTM through Mar 2026 was $3.7 billion, a 1.61% decrease from a year earlier, with the FY2025 full-year figure at $3.8 billion, down 2.05% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $3.7 billion, down from $3.8 billion in the prior quarter.
- Over the last five years, Goodwill & Intangibles for ZTS reached as high as $4.2 billion in Q3 2023 and fell as low as $1.4 billion in Q3 2022.
- Historically, Goodwill & Intangibles has averaged $3.8 billion across 5 years, with a median of $4.0 billion in 2024.
- Across the five-year window, Goodwill & Intangibles tumbled 68.26% in 2022 and soared 206.56% in 2023, its largest moves.
- Year by year, Goodwill & Intangibles stood at $4.1 billion in 2022, then fell by 0.7% to $4.1 billion in 2023, then decreased by 6.0% to $3.9 billion in 2024, then fell by 2.05% to $3.8 billion in 2025, then declined by 0.93% to $3.7 billion in 2026.
- Per Business Quant data, the three most recent Goodwill & Intangibles figures were $3.7 billion in Q1 2026, $3.8 billion in Q4 2025, and $3.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.74 Bn |
| Dec 31, 2025 | 3.77 Bn |
| Sep 30, 2025 | 3.80 Bn |
| Jun 30, 2025 | 3.83 Bn |
| Mar 31, 2025 | 3.80 Bn |
| Dec 31, 2024 | 3.85 Bn |
| Sep 30, 2024 | 3.93 Bn |
| Jun 30, 2024 | 3.97 Bn |
| Mar 31, 2024 | 4.05 Bn |
| Dec 31, 2023 | 4.10 Bn |
| Sep 30, 2023 | 4.16 Bn |
| Jun 30, 2023 | 3.97 Bn |
| Mar 31, 2023 | 4.05 Bn |
| Dec 31, 2022 | 4.13 Bn |
| Sep 30, 2022 | 1.36 Bn |
| Jun 30, 2022 | 4.11 Bn |
| Mar 31, 2022 | 4.12 Bn |
| Dec 31, 2021 | 4.16 Bn |
| Sep 30, 2021 | 4.28 Bn |
| Jun 30, 2021 | 4.36 Bn |